5VP1
Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
Functional Information from GO Data
| Chain | GOid | namespace | contents |
| A | 0004114 | molecular_function | 3',5'-cyclic-nucleotide phosphodiesterase activity |
| A | 0007165 | biological_process | signal transduction |
| A | 0008081 | molecular_function | phosphoric diester hydrolase activity |
| B | 0004114 | molecular_function | 3',5'-cyclic-nucleotide phosphodiesterase activity |
| B | 0007165 | biological_process | signal transduction |
| B | 0008081 | molecular_function | phosphoric diester hydrolase activity |
| C | 0004114 | molecular_function | 3',5'-cyclic-nucleotide phosphodiesterase activity |
| C | 0007165 | biological_process | signal transduction |
| C | 0008081 | molecular_function | phosphoric diester hydrolase activity |
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 6 |
| Details | binding site for residue ZN A 1001 |
| Chain | Residue |
| A | HIS660 |
| A | HIS696 |
| A | ASP697 |
| A | ASP808 |
| A | HOH1110 |
| A | HOH1116 |
| site_id | AC2 |
| Number of Residues | 6 |
| Details | binding site for residue MG A 1002 |
| Chain | Residue |
| A | HOH1110 |
| A | HOH1143 |
| A | HOH1173 |
| A | ASP697 |
| A | HOH1103 |
| A | HOH1108 |
| site_id | AC3 |
| Number of Residues | 5 |
| Details | binding site for residue MG A 1003 |
| Chain | Residue |
| A | GLU785 |
| A | HOH1135 |
| A | HOH1137 |
| A | HOH1180 |
| A | HOH1191 |
| site_id | AC4 |
| Number of Residues | 19 |
| Details | binding site for residue 9GA A 1004 |
| Chain | Residue |
| A | THR768 |
| A | LEU770 |
| A | HIS773 |
| A | THR805 |
| A | ASP808 |
| A | LEU809 |
| A | GLN812 |
| A | ILE826 |
| A | TYR827 |
| A | MET847 |
| A | LEU858 |
| A | GLN859 |
| A | PHE862 |
| A | ILE866 |
| A | ILE870 |
| A | HOH1114 |
| A | HOH1118 |
| A | HOH1122 |
| A | HOH1136 |
| site_id | AC5 |
| Number of Residues | 6 |
| Details | binding site for residue ZN B 1001 |
| Chain | Residue |
| B | HIS660 |
| B | HIS696 |
| B | ASP697 |
| B | ASP808 |
| B | HOH1111 |
| B | HOH1152 |
| site_id | AC6 |
| Number of Residues | 6 |
| Details | binding site for residue MG B 1002 |
| Chain | Residue |
| B | ASP697 |
| B | HOH1102 |
| B | HOH1111 |
| B | HOH1120 |
| B | HOH1124 |
| B | HOH1163 |
| site_id | AC7 |
| Number of Residues | 18 |
| Details | binding site for residue 9GA B 1003 |
| Chain | Residue |
| B | THR768 |
| B | LEU770 |
| B | HIS773 |
| B | THR805 |
| B | ASP808 |
| B | LEU809 |
| B | GLN812 |
| B | TYR827 |
| B | MET847 |
| B | LEU858 |
| B | GLN859 |
| B | PHE862 |
| B | ILE866 |
| B | ILE870 |
| B | HOH1113 |
| B | HOH1126 |
| B | HOH1134 |
| B | HOH1155 |
| site_id | AC8 |
| Number of Residues | 6 |
| Details | binding site for residue ZN C 1001 |
| Chain | Residue |
| C | HIS660 |
| C | HIS696 |
| C | ASP697 |
| C | ASP808 |
| C | HOH1103 |
| C | HOH1144 |
| site_id | AC9 |
| Number of Residues | 6 |
| Details | binding site for residue MG C 1002 |
| Chain | Residue |
| C | ASP697 |
| C | HOH1102 |
| C | HOH1103 |
| C | HOH1113 |
| C | HOH1120 |
| C | HOH1154 |
| site_id | AD1 |
| Number of Residues | 20 |
| Details | binding site for residue 9GA C 1003 |
| Chain | Residue |
| C | HIS656 |
| C | THR768 |
| C | LEU770 |
| C | HIS773 |
| C | THR805 |
| C | ASP808 |
| C | LEU809 |
| C | GLN812 |
| C | ILE826 |
| C | TYR827 |
| C | MET847 |
| C | LEU858 |
| C | GLN859 |
| C | PHE862 |
| C | ILE866 |
| C | ILE870 |
| C | HOH1112 |
| C | HOH1129 |
| C | HOH1130 |
| C | HOH1146 |
Functional Information from PROSITE/UniProt
| site_id | PS00126 |
| Number of Residues | 12 |
| Details | PDEASE_I_1 3'5'-cyclic nucleotide phosphodiesterase domain signature. HDLdHrGtnNsF |
| Chain | Residue | Details |
| A | HIS696-PHE707 |
Functional Information from SwissProt/UniProt
| site_id | SWS_FT_FI1 |
| Number of Residues | 3 |
| Details | Active site: {"description":"Proton donor","evidences":[{"source":"UniProtKB","id":"O76083","evidenceCode":"ECO:0000250"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI2 |
| Number of Residues | 9 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"15938621","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"19828435","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"23899287","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"1Z1L","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3IBJ","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3ITM","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3ITU","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"4HTX","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"4HTZ","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"4JIB","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI3 |
| Number of Residues | 3 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"15938621","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"19828435","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"23899287","evidenceCode":"ECO:0000269"},{"source":"PDB","id":"1Z1L","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3ITM","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"3ITU","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"4HTX","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"4HTZ","evidenceCode":"ECO:0007744"},{"source":"PDB","id":"4JIB","evidenceCode":"ECO:0007744"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI4 |
| Number of Residues | 324 |
| Details | Domain: {"description":"PDEase","evidences":[{"source":"PROSITE-ProRule","id":"PRU01192","evidenceCode":"ECO:0000255"}]} |
| Chain | Residue | Details |






